Authors:
LECHLER E
SCHRAMM W
FLOSBACH CW
BERGEMANN W
BROCKHAUS W
EGBRING R
GARBOR M
GEIDEL H
HENGSTMANN JH
JAGER K
KELLER F
LENZ K
LUDWIG M
MAURIN NJA
NIESSNER H
PICKLPFEFFER S
PLATT D
SCHAUER J
SCHENTKE KU
SCHULZ J
SLANY J
TEUFEL J
HALBRITTER R
THIELE G
THIER WH
TREESE N
WAGNER T
Citation: E. Lechler et al., THE VENOUS THROMBOTIC RISK IN NONSURGICAL PATIENTS - EPIDEMIOLOGIC DATA AND EFFICACY SAFETY PROFILE OF A LOW-MOLECULAR-WEIGHT HEPARIN (ENOXAPARIN), Haemostasis, 26, 1996, pp. 49-56
Authors:
SUBAT S
PIETZSCH J
FISCHER R
KASPER M
JULIUS U
SCHENTKE KU
EHNINGER G
Citation: S. Subat et al., EXPRESSION OF THE DESMOGLEIN-BAND-3-GLYCOPROTEIN ON HEPATOMA-CELL LINE HEPG2, Journal of experimental & clinical cancer research, 14(1), 1995, pp. 102-103
Authors:
DOMSCHKE W
DETTMER A
FENNER T
GREGOR M
HESSE P
HOLTMANN G
VANHUSEN N
MIEDERER SE
SCHENTKE KU
SCHUTZ E
STOLZLE L
WOSTENBERG D
Citation: W. Domschke et al., HELICOBACTER-PYLORI AND PEPTIC-ULCER IN 1 995 - THERAPEUTIC INDICATIONS AND RECOMMENDATIONS OF A MUNSTER EXPERT GROUP, Zeitschrift fur Gastroenterologie, 33(10), 1995, pp. 598-601
Authors:
PIETZSCH J
SUBAT S
NITZSCHE S
LEONHARDT W
SCHENTKE KU
HANEFELD M
Citation: J. Pietzsch et al., VERY FAST ULTRACENTRIFUGATION OF SERUM-LIPOPROTEINS - INFLUENCE ON LIPOPROTEIN SEPARATION AND COMPOSITION, Biochimica et biophysica acta, L. Lipids and lipid metabolism, 1254(1), 1995, pp. 77-88
Authors:
KURKTSCHIEV D
SUBAT S
ADLER D
SCHENTKE KU
Citation: D. Kurktschiev et al., IMMUNOMODULATING EFFECT OF URSODEOXYCHOLIC ACID THERAPY IN PATIENTS WITH PRIMARY BILIARY-CIRRHOSIS, Journal of hepatology, 18(3), 1993, pp. 373-377